Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [579]
News [1092]
Articles [59]
Editorials [2]
Conferences [100]
elearning [5]
An overview of the WIN consortium
Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical...
An overview of the WIN consortium ( Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA )
25 Apr 2019
Making oncology global with the WIN consortium
Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Making oncology global with the WIN consortium ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Apr 2019
The translational element of the WIN consortium
Dr Brian Leyland-Jones - WIN Head of Fundraising Committee
The translational element of the WIN consortium ( Dr Brian Leyland-Jones - WIN Head of Fundraising Committee )
25 Apr 2019
How the WIN consortium achieves its goals
Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA
How the WIN consortium achieves its goals ( Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA )
25 Apr 2019
Gynaecological cancer: Where are we now?
Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands
Gynaecological cancer: Where are we now? ( Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands )
21 Mar 2019
CB-839 in combination with cabozantinib in patients with clear cell and...
Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA
CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer ( Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA )
18 Feb 2019
ASCO GU 2019 renal highlights
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO GU 2019 renal highlights ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
14 Feb 2019
ARCHES trial: Androgen deprivation therapy with enzalutamide or placebo in mHSPC
Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA
ARCHES trial: Androgen deprivation therapy with enzalutamide or placebo in mHSPC ( Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA )
14 Feb 2019
CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line...
Dr Orazio Caffo - Santa Chiara Hospital, Trento, Italy
CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line chemotherapy for patients with mCRPC ( Dr Orazio Caffo - Santa Chiara Hospital, Trento, Italy )
14 Feb 2019
BGICC 2019
BGICC 2019 ( )
28 Jan 2019
Neoadjuvant hormonal treatment for luminal breast cancer: Rationale, evidence...
Prof Hope Rugo - University of California, San Francisco, USA
Neoadjuvant hormonal treatment for luminal breast cancer: Rationale, evidence and outcome ( Prof Hope Rugo - University of California, San Francisco, USA )
28 Jan 2019
Fertility issues during adjuvant treatment in premenopausal breast cancer...
Prof Valentina Guarneri - Università degli Studi di Padova, Padua, Italy
Fertility issues during adjuvant treatment in premenopausal breast cancer patients ( Prof Valentina Guarneri - Università degli Studi di Padova, Padua, Italy )
25 Jan 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation